Search Results - "Catenacci DVT"

Correction: Phase II Study Evaluating 2 Dosing Schedules of Oral Foretinib (GSK1363089), cMET/VEGFR2 Inhibitor, in Patients with Metastatic Gastric Cancer.

Authors: Shah, Manish A. Wainberg, Zev A. Catenacci, Daniel V. T. et al.

Source: PLoS ONE. 12/23/2021, Vol. 16 Issue 12, p1-1. 1p.

Multi-omics analysis uncovers predictive biomarkers for the efficacy and outcomes of chemoimmunotherapy in advanced unresectable biliary tract cancers.

Authors: Ni, Jiaojiao Li, Chaoqun Xu, Xiaoqing et al.

Source: BMC Medicine. 7/22/2025, Vol. 23 Issue 1, p1-17. 17p.

Advancing Ocular Safety Profile Assessment: A Novel Grading Scale for Ocular Adverse Reactions Associated with Bemarituzumab.

Authors: Farooq, Asim V. Kaur, Savreet Hundal, Pradeep et al.

Source: Ophthalmology & Therapy. Jul2025, Vol. 14 Issue 7, p1349-1356. 8p.

Evolving Landscape of HER2-Targeted Therapies for Gastric Cancer Patients.

Authors: He L Liu B Wang Z et al.

Source: Current treatment options in oncology [Curr Treat Options Oncol] 2025 Apr; Vol. 26 (4), pp. 260-277. Date of Electronic Publication: 2025 Mar 08.

Publication Type: Journal Article; Review

Journal Info: Publisher: Current Science, Inc Country of Publication: United States NLM ID: 100900946 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1534-6277 (Electronic) Linking ISSN: 15346277 NLM ISO Abbreviation: Curr Treat Options Oncol Subsets: MEDLINE

Endoscopic ultrasound‐guided vascular interventions.

Authors: Irisawa, Atsushi Nagashima, Kazunori Yamamiya, Akira et al.

Source: Digestive Endoscopy. Jan2025, Vol. 37 Issue 1, p85-92. 8p.

The immune signatures predict gastric/gastroesophageal junction cancer response to first-line anti-PD-1 blockade or chemotherapy.

Authors: Wu, Hui Shu, Wenzhi Ding, Yongfeng et al.

Source: BMC Cancer. 8/25/2025, Vol. 25 Issue 1, p1-14. 14p.

Calcium overload via PVT1 reprograms neutrophil fate and constrains gastric cancer progression.

Authors: Wang, Dong Li, Yunlong Peng, Xiaoyu et al.

Source: Journal of Translational Medicine. 8/7/2025, Vol. 23 Issue 1, p1-18. 18p.

The role and research progress of the MET signalling pathway in targeted therapy for osteosarcoma.

Authors: Su, Qilong Hou, Jingyu Du, Xinhui et al.

Source: Oncology Reviews. 2025, p1-9. 9p.

Correction: Phase II Study Evaluating 2 Dosing Schedules of Oral Foretinib (GSK1363089), cMET/VEGFR2 Inhibitor, in Patients with Metastatic Gastric Cancer.

Authors: Shah, Manish A. Wainberg, Zev A. Catenacci, Daniel V. T. et al.

Source: PLoS ONE. 10/10/2022, Vol. 17 Issue 10, p1-2. 2p.

Diffuse Gastric Cancer: A Comprehensive Review of Molecular Features and Emerging Therapeutics.

Authors: Wu LW Jang SJ Shapiro C et al.

Source: Targeted oncology [Target Oncol] 2024 Nov; Vol. 19 (6), pp. 845-865. Date of Electronic Publication: 2024 Sep 13.

Publication Type: Journal Article; Review; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural

Journal Info: Publisher: Springer-Verlag France Country of Publication: France NLM ID: 101270595 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1776-260X (Electronic) Linking ISSN: 17762596 NLM ISO Abbreviation: Target Oncol Subsets: MEDLINE

Next-generation neoantigen mRNA vaccines: Immuno-engineering strategies for precision cancer immunotherapy.

Authors: Li, Xiaoping Jabbarzadeh Kaboli, Parham Roozitalab, Ghazaal et al.

Source: Cellular Oncology (2211-3428). Apr2026, Vol. 49 Issue 2, p1-25. 25p.

Influence of salt solution on the physicochemical properties and in vitro/ in vivo expression of mRNA/LNP.

Authors: Tang, Siyuan Huang, Lei Ge, Jiahao et al.

Source: Journal of Nanobiotechnology. 3/19/2025, Vol. 23 Issue 1, p1-18. 18p.

Bioinformatic analysis indicated that LINC01150 might be a novel neutrophil extracellular traps-related biomarker of gastric cancer.

Authors: Qian, Yang-Yang Xu, Min Huang, Xin-Kun et al.

Source: Scientific Reports. 3/6/2025, Vol. 15 Issue 1, p1-16. 16p.

Capmatinib for High-Level MET-Amplified Metastatic Gastric Cancer Identified by Comprehensive Genomic Profiling: A Case Report and Literature Review.

Authors: Sato Y Watanabe K Matsuoka M et al.

Source: Journal of gastrointestinal cancer [J Gastrointest Cancer] 2026 Aug 07; Vol. 57 (1). Date of Electronic Publication: 2026 Aug 07.

Publication Type: Journal Article; Case Reports; Review

Journal Info: Publisher: Springer Country of Publication: United States NLM ID: 101479627 Publication Model: Electronic Cited Medium: Internet ISSN: 1941-6636 (Electronic) NLM ISO Abbreviation: J Gastrointest Cancer Subsets: MEDLINE

Circulating Tumor DNA Sequencing for Early Diagnosis and Detection of Treatment Response, Minimal Residual Disease, and Recurrence in Gastroesophageal Cancer.

Authors: Henriksen MM Rudbeck AV Detlefsen S et al.

Source: Journal of gastrointestinal cancer [J Gastrointest Cancer] 2026 Jul 21; Vol. 57 (1). Date of Electronic Publication: 2026 Jul 21.

Publication Type: Journal Article; Review

Journal Info: Publisher: Springer Country of Publication: United States NLM ID: 101479627 Publication Model: Electronic Cited Medium: Internet ISSN: 1941-6636 (Electronic) NLM ISO Abbreviation: J Gastrointest Cancer Subsets: MEDLINE

Prognostic implications of tissue-based homologous recombination deficiency in metastatic gastric cancer treated with immune checkpoint inhibitor plus chemotherapy.

Authors: Kim C Kim J Shin JE et al.

Source: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association [Gastric Cancer] 2026 Jul; Vol. 29 (4), pp. 816-826. Date of Electronic Publication: 2026 May 22.

Publication Type: Journal Article

Journal Info: Publisher: Springer-Verlag Tokyo Country of Publication: Japan NLM ID: 100886238 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1436-3305 (Electronic) Linking ISSN: 14363291 NLM ISO Abbreviation: Gastric Cancer Subsets: MEDLINE

Emerging molecular targets in gynaecologic cancers: clinical implications for personalized therapy.

Authors: Shaik B Thokala M Shaik F et al.

Source: Molecular biology reports [Mol Biol Rep] 2026 Jun 30; Vol. 53 (1). Date of Electronic Publication: 2026 Jun 30.

Publication Type: Journal Article; Review

Journal Info: Publisher: Reidel Country of Publication: Netherlands NLM ID: 0403234 Publication Model: Electronic Cited Medium: Internet ISSN: 1573-4978 (Electronic) Linking ISSN: 03014851 NLM ISO Abbreviation: Mol Biol Rep Subsets: MEDLINE

Prognostic Value of Circulating Tumor DNA-Based Minimal Residual Disease for Recurrence-Free Survival in Resectable Gastric Cancer: A Systematic Review and Meta-Analysis with Serial Monitoring Analysis.

Authors: Mehboob AA Iqbal AG Butt TS et al.

Source: Digestive diseases and sciences [Dig Dis Sci] 2026 Jun 03. Date of Electronic Publication: 2026 Jun 03.

Publication Type: Journal Article; Review

Journal Info: Publisher: Springer Science + Business Media Country of Publication: United States NLM ID: 7902782 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-2568 (Electronic) Linking ISSN: 01632116 NLM ISO Abbreviation: Dig Dis Sci Subsets: MEDLINE

Harnessing the power of cancer-associated fibroblasts to revolutionize pancreatic cancer treatment.

Authors: Shen, Jian Wu, Ruopu Yin, Tao et al.

Source: Cancer Biology & Medicine. Dec2025, Vol. 22 Issue 12, p1473-1492. 20p.

Safety profiles of IDH inhibitors: a pharmacovigilance analysis of the FDA Adverse Event Reporting System (FAERS) database.

Authors: Sun, Ximu Zhou, Han Li, Yanming et al.

Source: Future Journal of Pharmaceutical Sciences. 2/6/2025, Vol. 11 Issue 1, p1-12. 12p.